Free Trial

Brian Weinstein Analyst Performance

Analyst at William Blair

Brian Weinstein is a stock analyst at William Blair in the medical sector, covering 7 publicly traded companies. Over the past year, Brian Weinstein has issued 2 stock ratings, including buy and hold recommendations. While full access to Brian Weinstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Weinstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
19 Last 11 Years
Buy Recommendations
73.68% 14 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy73.7%14 ratings
Hold26.3%5 ratings
Sell0.0%0 ratings

Out of 19 total stock ratings issued by Brian Weinstein at William Blair, the majority (73.7%) have been Buy recommendations, followed by 26.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
85.7% of companies on NASDAQ
6 companies
NYSE
14.3% of companies on NYSE
1 company

Brian Weinstein, an analyst at William Blair, currently covers 7 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
7 companies
100.0%

Brian Weinstein of William Blair specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
2 companies
28.6%
MEDICAL SERVICES
1 company
14.3%
MED/DENTAL - SUPP
1 company
14.3%
MED INSTRUMENTS
1 company
14.3%
MED - BIOMED/GENE
1 company
14.3%
ANALYTICAL INSTRUMENTS
1 company
14.3%

Brian Weinstein's Ratings History at William Blair

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biodesix, Inc. stock logo
BDSX
Biodesix
2/27/2026Upgrade$14.22Outperform
Biodesix, Inc. stock logo
BDSX
Biodesix
5/14/2025Reiterated Rating$0.36Market Perform
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
5/1/2025Downgrade$175.72Market Perform